AI assistant
BIO-TECHNE Corp — Director's Dealing 2017
Feb 3, 2017
30718_dirs_2017-02-03_2819c584-8e6f-40e0-91d6-539c9430bc71.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2017-02-01
Reporting Person: Gavin Robert M. (Senior V.P. Protein Platforms)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-01 | Common Stock | M | 1667 | — | Acquired | 1667 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-01 | Stock Option (Right to Buy) | $93.32 | D | 33333 | Disposed | 2021-07-31 | Common Stock (33333) | Direct |
| 2017-02-01 | Restricted Stock Units | $ | M | 1667 | Disposed | Common Stock (1667) | Direct | |
| 2016-08-18 | Stock Option (Right to Buy) | $106.59 | A | 17371 | Acquired | 2023-08-18 | Common Stock (17371) | Direct |
| 2016-08-18 | Stock Option (Right to Buy) | $106.59 | A | 13028 | Acquired | 2023-08-18 | Common Stock (13028) | Direct |
| 2016-08-18 | Restricted Stock Units | $ | A | 2111 | Acquired | Common Stock (2111) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $93.32 | 2021-07-31 | Common Stock (10000) | 10000 | Direct |
| Stock Option (Right to Buy) | $90.25 | 2021-11-30 | Common Stock (5000) | 5000 | Direct |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (12500) | 12500 | Direct |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (9375) | 9375 | Direct |
| Restricted Stock Units | $ | Common Stock (1500) | 1500 | Direct |
Footnotes
F1: 2,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
F2: On 2/1/17, the Board of Directors authorized discretionary vesting for 16,667 performance options. The remainder of the performance options were forfeited.
F3: 1,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.
F4: On 2/1/17, the Board of Directors authorized discretionary vesting for 1,667 performance RSUs. The remainder of the performance RSUs were foreited.
F5: 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
F6: Each restricted stock unit represents a contingent right to receive one shares of Bio-Techne common stock.
F7: Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
F9: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).